LATE BREAKING ABSTRACT: A phase 1 study of PF-06647020, an antibody-drugconjugate targeting PTK7, in patients with advanced solid tumors

Date 27 September 2015
Event European Cancer Congress 2015
Session Early Drug Development II
Topics Drug Development
Presenter Tolcher, A.